Sanctuary Advisors LLC bought a new stake in Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 25,901 shares of the basic materials company’s stock, valued at approximately $2,638,000.
A number of other large investors also recently made changes to their positions in CCJ. Biondo Investment Advisors LLC purchased a new stake in shares of Cameco in the second quarter worth approximately $509,000. Solstein Capital LLC purchased a new position in Cameco during the second quarter valued at approximately $93,000. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Cameco during the second quarter valued at approximately $301,990,000. Bank of Nova Scotia acquired a new position in Cameco in the 2nd quarter valued at approximately $129,887,000. Finally, Elevation Point Wealth Partners LLC acquired a new position in Cameco in the 2nd quarter valued at approximately $950,000. Institutional investors and hedge funds own 70.21% of the company’s stock.
Cameco Price Performance
NYSE CCJ opened at $107.03 on Wednesday. The company has a quick ratio of 2.10, a current ratio of 3.06 and a debt-to-equity ratio of 0.14. The stock has a market capitalization of $46.61 billion, a PE ratio of 181.40, a price-to-earnings-growth ratio of 1.75 and a beta of 1.05. Cameco Corporation has a 12-month low of $73.20 and a 12-month high of $135.24. The company has a 50 day moving average price of $96.10 and a two-hundred day moving average price of $107.18.
Wall Street Analysts Forecast Growth
A number of equities research analysts have issued reports on CCJ shares. Weiss Ratings lowered shares of Cameco from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, August 12th. Truist Financial upped their price target on shares of Cameco from $129.00 to $130.00 and gave the stock a “buy” rating in a research note on Wednesday, August 12th. Wall Street Zen lowered Cameco from a “hold” rating to a “sell” rating in a report on Saturday, August 8th. Royal Bank Of Canada lifted their price objective on Cameco from $160.00 to $175.00 and gave the company an “outperform” rating in a research report on Monday, June 29th. Finally, Bank of America lowered their target price on Cameco from $143.00 to $140.00 and set a “buy” rating on the stock in a research note on Thursday, July 9th. Fourteen research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $145.68.
Read Our Latest Stock Report on Cameco
About Cameco
Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.
The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.
Featured Articles
- Five stocks we like better than Cameco
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding CCJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO).
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.
